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Mechanisms of lung regeneration after injury remain poorly understood. Bone morphogenetic protein 4
(BMP4) is critical for lung morphogenesis and regulates differentiation of the airway epithelium during
development, although its mechanism of action is unknown. The role of BMPs in adult lungs is unclear. We
hypothesised that BMP signalling is involved in regeneration of damaged adult airways after injury. Our aims
were to characterise the regeneration process in 1-nitronaphthalene (1-NN) injured airways, to determine if
and when BMP signalling is activated during this process and investigate the effects of BMP4 on normal adult
airway epithelial cells (AECs). Rats were injected with 50 mg/kg 1-NN and protein expression in AECs was
examined by Western blotting of lung lysis lavage, and by immunofluorescence, at 6, 24, 48 and 96 h post
injection. Expression of signalling molecules p-ERK-1, p-ERK-2 and p-Smad1/5/8 in AECs peaked at 6 h post
injection, coincident with maximal inflammation and prior to airway denudation which occurred at 24 h.
While airways were re-epithelialised by 48 h, AEC proliferation peaked later at 96 h post 1-NN injection. In
vitro, BMP4 induced a mesenchymal-like morphology in normal AECs, downregulated E-cadherin expression
and increased migration in a wound closure assay. Thus, following acute injury, increased BMP signalling in
AECs coincides with inflammation and precedes airway denudation and re-epithelialisation. Our data indicate
that, similar to its role in controlling tissue architecture during development, BMP signalling regulates
regeneration of the airways following acute injury, involving downregulation of E-cadherin and induction of
migration in AECs.
© 2010 Elsevier Inc. All rights reserved.
1. Introduction
Mechanisms underlying regeneration of the airways after injury
remain poorly understood. While significant progress has been made
in recent years in identifying the progenitor cell types responsible for
regenerating the airway epithelium after injury, the signals that
control the regeneration process remain unclear. It has been
postulated that developmental signals necessary for lung morpho-
genesis during development may also be involved in regeneration in
injured adult lungs but few studies have directly addressed this
question [1].
Bone morphogenetic proteins (BMPs) are highly conserved mem-
bersof the transforminggrowth factorβ (TGFβ) superfamily andare key
regulators of tissue structure both during development and in adult
organisms. Over 30 different BMP ligands have been identified and
shown to influence processes including stem cell maintenance, cell
proliferation, migration, differentiation and apoptosis [2]. BMP4 plays a
critical role in a varietyof developmental processes including epithelial–
mesenchymal transition (EMT) aspects of morphogenesis [2] and early
mesoderm formation [3]. BMP signalling is mediated via type I and type
II receptors. Following ligand binding, the type II receptor (BMPR-II)
transphosphorylates the type I receptors (BMPR-IA or BMPR-IB) (2). In
the canonical pathway, activated type I receptors recruit and phos-
phorylate the receptor-regulated Smads (R-Smads) 1, 5 and/or 8.
Activated R-Smads form heteromeric complexes with Smad4 and
translocate to the nucleus where they act as transcriptional co-
modulators of specific target genes.Non-canonical signalling also occurs
through mitogen-activated protein kinases, phosphoinositide 3-kinase
and LIM kinase [4].
BMP4 is essential for lung morphogenesis and also modulates
proximal–distal differentiation of the developing epithelium although
the mechanism involved is unknown [5]. Few studies have addressed
the role of BMP signalling in adult lungs. In amouse study of ovalbumin
(OVA)-induced allergic airway inflammation, BMP signalling was
examined at a single time point, 24 h, post-OVA challenge [6].
Immunostaining revealed that all of the BMP type I receptors, including
BMPR-IA, were upregulated in inflamed bronchial epithelial cells and
induction of BMP2 and BMP4 protein expressionwas detected in whole
lung homogenates from OVA-treated animals. While Smad1
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immunostaining was observed in all bronchial epithelial cells in both
control and OVA-treated animals, phosphorylated Smad1/5 (p-Smad1/
5) was only detected in OVA-treated airways. A study in human
asthmatic airways described a somewhat different profile of BMP
pathway immunostaining [7]. In contrast to the mouse OVA study,
expression of p-Smad1/5 was detected in both normal and inflamed
airwayepithelial cellswith the incidence reduced in baseline asthmatics
and increased following allergen challenge. Therefore, it is unclear
whether the canonical BMP signalling pathway is active in normal
airway cells and its precise role in health or disease is unknown. We
have shown previously that BMP4 downregulates E-cadherin in a
transformed airway epithelial cell line [8]. However, it has not yet been
established whether normal airway epithelial cells are responsive to
BMP2 or BMP4 and the subsequent cellular effects of these ligands are
also unknown.
We hypothesise that the key role played by BMP4 in forming the
lungs during development is recapitulated in adult lungs during
regeneration after injury. Recent reports that BMP signalling regulates
epithelial regeneration followingdamage in theadult zebrafish liver and
mouse bladder support this hypothesis [9,10]. In the present study, we
investigated whether BMP signalling is activated in airway epithelial
cells in vivo following acute lung injury and the timing of such activation
during regeneration relative to inflammation, epithelial damage and re-
epithelialisation. For this, we first characterised the chronology of
injury/inflammation/regeneration in the 1-nitronaphthalene (1-NN)
ratmodel of acute lung injury.We then used a combination of lung lysis
lavage [11] and immunofluorescence to examine BMP signalling
specifically within airway epithelial cells. We also determined whether
normal airway epithelial cells are responsive to BMP4 and investigated
the effects of BMP4 on these cells.
2. Materials and methods
2.1. Animals and 1-nitronapthalene treatment
Allworkwas carried out in accordancewith the ECDirective 86/609/
EEC for animal experiments. All animal usewas approved in advance by
the Animal Use and Care Committee at the University of California,
Davis, USA (UCDavis). Male Sprague–Dawley ratswere purchased from
Harlan (Indianapolis, IN, USA). Animalswere fed andwatered ad libitum
and housed in an American Association for Accreditation of Laboratory
Animal Care accredited facility in HEPA-filtered cage racks at UC Davis
for 7 days prior to use. Thirty two rats (225–250 g, aged 8–10 wks)were
randomly assigned to eight experimental groups (n=4). Rats were
treated by single intraperitoneal injection with 50 mg/kg body weight
1-nitronapthalene (1-NN) diluted in oleic oil or with oleic oil alone
(vehicle control). All treatments were administered between 8 am and
10 am. Groups (n=4) of 1-NN or vehicle-treated rats were sacrificed at
6, 24, 48 and 96 h following administration of treatments with an
overdose intraperitoneal injection of sodium pentobarbital.
2.2. Lung epithelial cell-enriched lysis lavage, bronchoalveolar lavage
fluid analysis, lung tissue fixation and haematoxylin and eosin staining
Rat lungs (n=3) were processed for lysis lavage as described
previously [11]. Briefly, rats were sacrificed and the trachea was
exposed and cannulated. The lungs were removed from the thoracic
cavity and inflated with agarose solution immediately followed by
dextrose solution. Both solutions were preheated to 37 °C. The
inflated lungs were incubated in a chilled 5% dextrose bath to allow
the agarose to solidify. The dextrose solution was then removed
through the cannula and stored on ice. The airways were then lavaged
with lysis buffer containing 2 M thiourea, 7 M urea, 4% wt/vol CHAPS,
0.5% wt/vol Triton X-100, 1% wt/vol DTT, and 2% vol/vol protease
inhibitor cocktail III (Calbiochem, La Jolla, CA). The epithelial cell-
enriched lysate was recovered immediately, flash frozen on dry ice
and stored at−80 °C until use. Protein concentration was determined
using the Bradford assay. Total cell counts were obtained from the
dextrose solution recovered from the airways during lysis lavage. Rat
lungs (n=1) were fixed in 1% paraformaldehyde overnight at 4 °C,
paraffin embedded and 4 μm sections were stained by routine
haematoxylin and eosin staining.
2.3. Primary airway epithelial cell isolation and BMP4 treatment
Normal primary mouse AECs were harvested from euthanized
(sodium pentabarbitol overdose) female C3H-Hen mice as described
previously [12]. Freshly isolated AECs were seeded onto fibronectin-
coated glass multiwell chamber slides (Nunc, Roskilde, Denmark) in
plating medium (Dulbeco's Modified Essential Medium (Gibco, Glasgow,
UK), 10% fetal bovine serum, 2 mM L-glutamine (Gibco), 100 U/ml
penicillin and 100 μg/ml streptomycin (Gibco)). The following day, cells
were rinsed once with serum-free Hams F12 basal medium and then
cultured in defined serum-free medium (SFM) (1:1 Hams F12:M199
(Gibco)), 2 mML-glutamine, 100 U/mlpenicillin, 100 μg/ml streptomycin,
100 U/ml insulin-transferin-selenium (Gibco), 100 ng/ml hydrocortisone
(Sigma-Aldrich, Dublin, Ireland) and 10 ng/ml epidermal growth factor
(R&D Systems, Minneapolis, USA). After 24 h, supernatant was removed
and fresh SFMwas added containing appropriate concentrations of BMP4.
2.4. Wound closure assay
The wound closure assay is a modification of the Platypus
Technologies Oris Cell Migration Assay (Abingdon, UK). Each well of
an Oris 96-well plate was prepared as follows: the centre of the well
was coated with 50 ng/ml fibronectin, allowed to dry for 2 h and a
stopper was then placed in the well to cover the fibronectin; the outer
ring of the well was then coated with 50 ng/ml collagen overnight at
4 °C; excess collagen was removed and primary mouse AECs were
seeded in plating medium into this outer area. After 2 days, plating
medium was replaced with SFM. On day 5, plugs were removed and
medium was replaced with SFM containing 100 ng/ml BMP4 or 10%
FCS. After 24 h, cells were stained with Giemsa stain (Sigma-Aldrich,
Dublin, Ireland). The Oris ‘detection mask’ was used to visualize the
wound area which was photographed and migrated cells were
counted using Adobe Photoshop CS3 Extended Cell Count software.
2.5. Western blotting for rat lung lysis lavage proteins and mouse airway
epithelial cell proteins
Western blotting and densitometric analyses were carried out as
previously described [8]. Primary antibodies used were: actin (clone
20–33, Sigma-Aldrich) and pERK, T-ERK and p-Smad1/5/8 (Phospho-
Smad1 (Ser463/465)/Smad5 (Ser463/465)/Smad8 (Ser426/428)) (Cell
Signalling Technology, Danvers, MA, USA).
2.6. Immunofluorescence of lung tissue and cultured lung cells
Lung tissues were deparaffinised in xylene, rehydrated and
antigen retrieved by boiling in citrate buffer. Cultured cells were
fixed with pre-chilled methanol. Tissue sections and cells were
incubated with primary antibodies overnight at 4 °C followed by
appropriate Alexa Fluor® 488-labeled secondary antibodies (Molec-
ular Probes, Invitrogen, Paisley, UK) for 30 min at room temperature.
Nuclei were counterstained with DAPI (Sigma-Aldrich). In addition to
antibodies described earlier, primary antibodies used were: PCNA
(clone PC 10, Sigma-Aldrich), E-cadherin (clone 36, BD Biosciences,
Oxford, UK) and Smad5 (clone D-20) and Smad8 (clone A-17) from
Santa Cruz Biotechnology, Santa Cruz, CA, USA.
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2.7. Quantitative PCR and RT-PCR
Quantitative PCR for E-cadherin and RT-PCR for Snai1 was carried
out as described previously [8]. Samples (n=2) were run in triplicate
and GAPDH was used as the endogenous control.
3. Results
3.1. Characterisation of regeneration process in rat airways following
1-nitronaphthalene-induced acute lung injury
The cytotoxicant naphthalene and its derivatives have been widely
used to study acute injury mechanisms and to identify stem/progenitor
populations in rodent airways [13–15]. Few studies however have used
these models to identify the growth factor signals that drive airway
regeneration following injury. 1-Nitronaphthalene (1-NN) is considered
the most toxic of the naphthalene derivatives and occurs in cigarette
smoke, diesel exhaust and in ambient air [16]. Toxicological processes
have been described previously in rat 1-NN models with most studies
focusing on the 24 hour period post 1-NN exposure and few studies
extending to 48 h [17]. High levels of cytochrome P450 2B1 in rat Clara
cells in the airways are thought to bioactivate 1-NN leading to Clara cell
death and also death of neighbouring ciliated cells [16]. Cell death is
accompanied by mild leukocytic infiltration, however injury remains
localised to the epithelium [17]. In order to identify the signals that
control regeneration of the airway epitheliumafter injury,we examined
lung regeneration processes in rats exposed to 50 mg/kg 1-NN at times
up to 96 h post exposure.
We were interested in determining a time course of BMP signalling
relative to inflammation and epithelial injury, proliferation and
restoration. Ultrastructural alterations in response to 1-NN up to 96 h
post exposurewere examined in haematoxylin and eosin stained tissue
sections in order to characterise for the first time the chronology of
airway inflammation/injury/regeneration in this model. No histological
evidence of epithelial injury was apparent at 6 h post 1-NN injection
(Fig. 1A). However, at 24 h following administration, substantial airway
epithelial damagewas observed at all airway levels. The epitheliumwas
discontinuous with regions exhibiting loss of epithelial cells and
denudation of the basement membrane. By 48 h post exposure, the
airway surface was re-epithelialised.
The time course of inflammation induced by1-NN-mediated toxicity
was examined. Cellular infiltration of the airway lumen was quantified
from bronchoalveolar lavage (BAL) fluid at 6, 24, 48 and 96 h post 1-NN
exposure. This infiltrate wasmaximal at 6 h following administration of
1-NN and subsequently decreased over the time course analysed. We
now show here that infiltration remained depressed at 96 h (Fig. 1B).
Fig. 1. Time course analysis of injury, inflammation and regeneration in airways of 1-NN-treated animals over 96 h. (A) Histological analysis of haematoxylin and eosin stained control
(a–d) and 1-NN-treated (e–h) tissues. At 6 h post injection, the airway epithelium appeared normal in 1-NN-treated animals (e) while at 24 h, the epithelium was discontinuous with
regions exhibiting loss of epithelial cells and denudation of the basementmembrane (arrows) (f). At 48 h and 96 h post injection, the airways were re-epithelialised. (B) Bronchoalveolar
lavage (BAL)fluid infiltratewasmaximal at 6 h post 1-NN injection. Each timepoint represents n=3except for 48 hwhich represents n=2. (C)Densitometric analysis ofWestern blots of
lung lysate lavage revealed that PCNA levels were significantly increased 1.8-fold in AECs in 1-NN-treated animals at 96 h compared to controls, n=3. (D) Immunofluorescence of tissue
sections demonstrated regions of focal PCNA-positive AECs at 96 h. Significance compared to control cells was obtained using the Student's t test (*Pb0.05). Scale bars represent 50 μm.
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To characterise the regeneration process following 1-NN-mediated
injury, the timing of airway epithelial cell proliferation was deter-
mined by examining proliferating cell nuclear antigen (PCNA)
expression. In order to quantify the levels of PCNA specifically within
the regenerating airway epithelium, lung lysis lavage was carried out.
This technique generates lysates that are highly enriched for AEC
proteins directly from whole lungs while leaving the basement
membrane intact and as such differs from previous studies of BMP
signalling in lungs that have been limited to analysis of whole lung
lysates [6,7]. Western blotting of these lysates revealed that PCNA
levels were significantly increased 1.8-fold in AECs in 1-NN-treated
animals at 96 h compared to controls (Fig. 1C). Immunofluorescence
for PCNA in lung tissue sections was also carried out. When present in
the airway epithelium, PCNA was localised to the nuclei of AECs. Low
numbers of PCNA-positive epithelial cells were evident in control
airways at all time points (data not shown). An increased incidence of
PCNA-positive cells was observed in 1-NN treatment groups at the
96 hour time point compared to control lungs, consistent with the
lung lysis lavage data (Fig. 1D).
Thus we confirmed that in this acute injury model, inflammation
preceded airway denudation (at 6 h and 24 h post 1-NN respectively).
Importantly, we established here that airway re-epithelialisation was
underway at 48 h and that proliferation did not occur until the later
96 h time point. This indicates that re-epithelialisation at 48 h
following acute injury is primarily due to cell migration rather than
proliferation.
3.2. ERK and Smad activation in airway epithelial cells following 1-NN injury
Having established the chronology of injury, inflammation, re-
epithelialisation and proliferation, we wanted to identify signalling
pathways involved in airway regeneration following acute injury, and
the time course of their activation. As amediator of a rangeof signalling
pathways including BMPs, the activation of ERK-1/2 was examined in
lung lysates from control and 1-NN-treated animals. Involvement of
the canonical BMP signalling pathway was also investigated.
At 6 h post exposure, levels of phosphorylated ERK-1 and ERK-2
(p-ERK-1 and p-ERK-2) were upregulated 3.5-fold and 10-fold
respectively in AECs of 1-NN-treated animals compared with controls
(Fig. 2A, B). At subsequent time points, levels of p-ERK-1 and p-ERK-2
were lower in 1-NN-treated AECs than in control cells.
Specific BMP signalling was also activated in lungs of 1-NN-treated
rats. An antibody which detects phosphorylated Smads 1, 5 and/or
8 (p-Smad1/5/8) was used to assess Smad phosphorylation status.
p-Smad1/5/8 was detected in AEC lysates from both control and 1-NN-
treated animals at all time points (Fig. 2A). At 6 h post 1-NN treatment,
p-Smad1/5/8 levels were significantly increased 0.6-fold in AECs of
animals exposed to 1-NN compared to controls (Fig. 2A, B). At the later
time points, p-Smad1/5/8 levels were not significantly different
between treated and control animals.
Localisation of p-Smad1/5/8 was also examined by immunofluo-
rescence in lung tissue sections. Consistent with the lung lysis lavage
analysis, p-Smad1/5/8 was present in AECs of control animals and
increased levels of p-Smad1/5/8 immunostaining were evident in
AECs at 6 h in lungs from 1-NN-treated animals compared with
controls (Fig. 2C).
3.3. Airway epithelial cells are responsive to BMP4
We next sought evidence as to which specific BMP ligand may be
involved in activating Smad signalling in AECs. While expression of
BMP4 has been reported in healthy and inflamed airway epithelial
cells [7], it has not yet been confirmed whether normal AECs are in
fact responsive to this BMP ligand. Rather than autocrine epithelial
signalling, AECs may be non-responsive to the BMP4 they produce
and mesenchymal cells may be the target for paracrine BMP4 signals
emanating from the epithelium. Furthermore, the consequences of
any such BMP4-mediated signalling in AECs are unknown.
We examined whether BMP4 was capable of activating Smad
proteins in primary airway epithelial cells. Expression and nuclear
localisation of Smad5, Smad8, p-Smad1/5/8 and Smad4 were examined
by immunofluorescence. In the first instance, Smad expression was
assessed in AECs in the absence of exogenous BMPs. All Smads were
detected in these untreated cells (Fig. 3Aa–d). Smad5 was predom-
inantly cytoplasmic with a low incidence of nuclear localisation. Smad8
was predominantly cytoplasmic in untreated AECs. p-Smad1/5/8 was
predominantly localised to the nuclei of untreated AECs while Smad4
was cytoplasmic. The presence of p-Smad1/5/8 in the nucleus of
untreated cells indicates that these cells express BMPs and respond to
them in an autocrine manner. The expression of these Smad proteins
was examined after 20 min and 2 h exposure to 100 ng/ml BMP4.
Cytoplasmic levels of Smad5were increased following 20 min exposure
to BMP4 and increased nuclear localisation of both Smad5 and Smad8
was also apparent in BMP4-treated cells (Fig. 3Ae,f). The incidence of
nuclear localised p-Smad1/5/8 did not appear upregulated after 20 min
or 2 h exposure to BMP4 but was increased after 17 h (not shown).
Smad4was predominantly localised to the nucleus of AECs treatedwith
BMP4 for 2 h (Fig. 3Ah).
Increased p-Smad1/5/8 expression levels in AECs in response to
BMP treatment were also detected by Western blotting. Levels of
p-Smad1/5/8 were upregulated 0.5-fold in AECs exposed to 100 ng/ml
BMP4 for 72 h (Fig. 3B and C).
3.4. BMP4 alters morphology and downregulates E-cadherin expression
in primary airway epithelial cells
We have reported previously that BMP4 induces a mesenchymal-
like morphology and downregulates E-cadherin expression in
BEAS-2B transformed human airway epithelial cells [8]. However,
the effects of BMP4 on normal AECs, including effects on E-cadherin
expression, are unknown. We therefore examined the effect of BMP4
on morphology and E-cadherin expression in normal primary AECs.
Primary AECs cultured in control medium displayed characteristic
epithelial ‘cobblestone’ morphology (Fig. 4Aa). In contrast, AECs
culturedwith100 ng/mlBMP4exhibitedmarkedchange inmorphology
with many cells appearing elongated and scattered with a mesenchy-
mal-like morphology (Fig. 4Ab).
The effect of BMP4 on E-cadherin expression in these cells was
examined. Immunofluorescence revealed that E-cadherin expression
was downregulated at cell membranes of AECs cultured with BMP4
compared with untreated cells (Fig. 4Ac, d). Western blotting
confirmed that E-cadherin levels were decreased in BMP4-treated
cells to 50% of the level observed in untreated cells (Fig. 4B and C). The
E-cadherin antibody used in this study recognises both the full length
E-cadherin (120 kDa) and a truncated form of the protein (~33 kDa).
This truncated form represents posttranslational regulation of E-
cadherin-mediated adherens junction stability [18] and is often
observed in E-cadherin Western blots. Levels of this truncated form
of E-cadherin were reduced in proportion to those of full length E-
cadherin following BMP4 treatment (Fig. 4B and C). This suggests that
the reduction in levels of full length E-cadherin in response to BMP4
was not due to an increase in posttranslation cleavage of the protein, a
possible mechanism for downregulation of E-cadherin [18].
Quantitative PCR was therefore carried out to determine whether
BMP4 induced transcriptional downregulation of E-cadherin. E-
cadherin mRNA expression was reduced 0.28-fold and 1.58-fold in
AECs in response to 50 and 100 ng/ml BMP4 respectively (Fig. 4D).
We and others have shown that BMP4 upregulates transcriptional
repressors of E-cadherin including Snai1 [8,19] but this has not been
demonstrated to date in normal AECs. We therefore examined the
effects of BMP4 on Snai1 expression in these cells. Snai1 expression
was elevated in AECs in response to 100 ng/ml BMP4.
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3.5. BMP4 enhances migration of airway epithelial cells in a wound
closure assay
Given that in vivo in 1-NN injured airways, increased Smad
signalling coincides with the migration phase of regenerating airways
and that in vitro, BMP4 induced a mesenchymal-like morphology and
downregulated E-cadherin in primary AECs, we used a novel wound
closure assay to determine whether BMP4 enhances migration of
these cells. In this assay, AECs are seeded intomultiwell plates onto an
outer ring area coated with collagen type IV and allowed to become
confluent. The centre of the ring has been coated with fibronectin to
mimic a wound area and is covered with a stopper to prevent cell
attachment.When the cells in the outer ring are confluent, the stopper
is removed to expose the fibronectin ‘wound’ and the cells are allowed
to migrate.
BMP4 increased the rate of migration of cells into the wound area.
The number of cells in thewound areawas 0.77-fold greater (n=3) in
the presence of BMP4 than that in control SFM 24 h after removal of
the stopper (Fig. 5A and B). Migration in the presence of BMP4 was
also slightly enhanced compared to the 10% FCS positive control.
4. Discussion
To date, understanding of the expression of BMP signalling pathway
components in normal, injured anddiseased lungshas beenvery limited
and the role of BMP signalling in normal airway epithelial cells has been
unknown. We have previously shown that BMP4 downregulates E-
cadherin expression and increases motility of transformed airway
epithelial cells [8]. We subsequently hypothesised that, if replicated in
vivo and in primary airway cells, these effects of BMP signalling could
Fig. 2. Expression of signalling proteins in airway epithelium of control and 1-NN-treated animals. (A) Western blots of lung lysis lavage from control vehicle-treated (n=3) and 1-NN-
treated (n=3) animals showing expressionof signallingmolecules in airwayepithelial cells. (B) Densitometric analysis of blots showed that levels of p-ERK-1 andp-ERK-2were increased
at 6 h post 1-NN treatment compared to vehicle controls. Levels of p-Smad1/5/8were also increased at 6 h in1-NN injured airway epitheliumcomparedwith vehicle controls. p-ERK-1 and
p-ERK-2 were normalised to total ERK-1 and ERK-2 (T-ERK-1 and T-ERK-2) respectively and p-Smad1/5/8 was normalised to actin. (C) Immunofluorescence revealed p-Smad1/5/
8 expression in control airway epithelial cells and increased expression in cells from1-NN-treated animals at 6 h. All densitometry data represent n=3 animals. Significance compared to
controls was obtained using the Student's t test (*Pb0.05). Scale bars represent 20 μm.
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play an important role in normal and disease processes including
regeneration, inflammation and carcinogenesis. In thepresent study,we
examined epithelial regeneration, utilising the rat 1-NN acute injury
modelwhichhas been used previously primarily for toxicity studies and
inwhich the timeframe of airway epithelial regenerationwas unknown.
Our study provides novel insight into the chronology of regeneration
Fig. 3. BMP4 activates Smad signalling in normal airway epithelial cells. (A) Representative photomicrographs of Smad protein expression in untreated cells and cells treated with
100 ng/ml BMP4 for 20 min or 2 h. Nuclear (arrows) and/or cytoplasmic expression of Smad5, Smad8, p-Smad1/5/8 and Smad4 was detected in normal AECs in the absence of
exogenous BMP ligand (a–d). Increased incidence of nuclear localisation of all Smads was observed following addition of BMP4 (e–h). Scale bar represents 100 μm. (B) Western
blotting and (C) densitometric analysis (n=2, normalised to actin) confirmed that levels of p-Smad1/5/8 remained elevated in normal AECs cultured in the presence of 50 ng/ml or
100 ng/ml BMP4 for 72 h.
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events that follow acute airway injury and the involvement of BMP
signalling in regeneration in vitro and in vivo.
Our observations of maximal inflammation and airway damage at
6 h and 24 h respectively are consistent with previous studies
concerned with the toxicology of 1-NN. The airway cell types affected
by 1-NN-mediated toxicity at 24 h post exposure have been described
previously in a detailed histopathological evaluation of 1-NN toxicity
in rat lungs. At doses of 50 mg/kg 1-NN, ciliated cell toxicity is
minimal while nonciliated (Clara) cell loss is equally prevalent in all
airway levels resulting in a discontinuous epithelium with focal
denudation of the basement membrane [13]. In our study, we now
demonstrate that 1-NN-induced inflammation coincides with early
elevation of ERK and Smad1/5/8 signalling activity in AECs, and
significantly, that this occurs prior to airway denudation. We also
show that re-epithelialisation occurs by 48 h post 1-NN administra-
tion. The fact that cell proliferation was maximal at 96 h post 1-NN
exposure indicates that re-epithelialisation is mainly due to migration
of remaining epithelial cells rather than proliferation. This is
consistent with current understanding that a cell migration phase
precedes a proliferation phase during airway epithelial regeneration
[20].
The two previous studies of BMP signalling pathway components
in mouse and human inflamed airways used Western blotting of
whole lung lysate and immunostaining to examine protein expression
and reported differing observations of p-Smad1/5 in normal airway
epithelial cells [6,7]. In contrast, our use of the lung lysis lavage
technique combined with immunofluorescence for this study has
allowed us to precisely localise and quantify signalling molecules in
AECs in vivo. With both techniques, we observed p-Smad1/5/
8 immunoreactivity in both normal and regenerating rat airway
epithelium, consistent with the previous study of human asthmatic
airways [7]. Thus, unlike ERK signalling, the canonical BMP Smad
signalling pathway is constitutively active in healthy airway epithelial
cells, indicating an as yet unknown role in maintenance of cell
Fig. 4. Effect of BMP4 on morphology and E-cadherin expression in normal airway epithelial cells. (A) Untreated AECs showed a typical epithelial morphology (a) while AECs
culturedwith 100 ng/ml BMP4 for 72 h displayed an alteredmorphology with cells acquiring an elongatedmesenchymal-like appearance (b) and immunofluorescence revealed that
E-cadherin expression was reduced at regions of cell–cell contact in these cells (c, d). (B) and (C)Western blotting and densitometry (n=2) confirmed that E-cadherin protein levels
were reduced in AECs cultured with BMP4 for 72 h. A concomitant reduction in a 30 kDa truncated form of E-cadherin also occurred. (D) Quantitative PCR revealed that mRNA levels
of E-cadherin were reduced in AECs cultured with BMP4 for 48 h (n=2). (E) Semi-quantitative RT-PCR showed that Snai1 expression was increased in AECs cultured with BMP4 for
48 h (n=2 except 100 ng/ml BMP4 n=4).
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function. It is not yet clear which cell types within the epithelium
possess this constitutive Smad activity and if the increase following
injury occurs in these same cells or in another subpopulation.
The elevation of ERK and Smad1/5/8 activation at the 6 hour time
point, before epithelial injury was evident histologically at 24 h,
suggests that their respective pathways play key early roles in the
regeneration process. This signalling coincided with the period of
inflammatory cell infiltration. Therefore, inflammation, rather than
tissue damage, may be the critical signal for activation of a regeneration
response in injured AECs. However, there may be a two-way
communication between inflammatory cells and epithelial cells. We
reported previously that vascular cell adhesion molecule 1 (VCAM1)
mRNA is highly upregulated in transformed airway epithelial cells
stimulated with BMP4 [8]. VCAM1 is involved in leukocyte migration
during inflammation [21].We have not examined VCAM1 expression in
the present study but if BMP4 has a similar effect on airway cells in vivo,
this could be a mechanism whereby BMP signalling activates airway
epithelial cells to increase inflammatory cell infiltration following
injury.
BMP4 is expressed in epithelial cells in the tips of growing mouse
lung buds [5] and is reportedly expressed throughout the airway
epithelium, in submucosal cells and in inflammatory cells in adult
human airways [7]. In the mouse and human allergic lung inflamma-
tion studies, levels of BMP4 did not increase during inflammation
[6,7]. This suggests that constitutively expressed BMP4, probably from
damaged epithelial cells and possibly from local inflammatory cells, is
a likely source of BMP ligand in our 1-NN acute injury model.
Importantly, the demonstration that nuclear p-Smad1/5/8 is present
in untreated normal AECs here (Fig. 3Ac) indicates that these cells
produce BMPs and are responsive in an autocrine manner. BMP4 is
critical to a variety of developmental processes, including EMT aspects
of morphogenesis, and transcriptional repression of E-cadherin is a
key step in EMT [22]. The use of primary AEC cultures enabled us to
demonstrate for the first time that normal AECs are responsive to
BMP4 and that a consequence of BMP4 signalling in these cells is the
downregulation of E-cadherin mRNA and protein expression. There-
fore, we have shown that the ability of BMP4 to downregulate
epithelial-related proteins during morphogenesis is recapitulated in
normal adult airway epithelial cells. We therefore suggest that the
role of BMP4 as lungmorphogen during development is recapitulated,
at least to some degree, in adult lungs when airways undergo
regeneration following injury. The combined data from this study and
our previous study [8] suggest that in injured airways in vivo, BMP4
signalling in AECs is an early event following injury, resulting in
migration of epithelial cells across the denuded basement membrane
and that downregulation of E-cadherin may be required for this
process. It is conceivable that in vivo, inappropriately sustained BMP
signalling, possibly as a result of chronic injury/inflammation, could
result in a prolonged decrease in E-cadherin expression in the
airways. This in turn could compromise epithelial barrier integrity
in the short term and could possibly lead to remodelling, EMT or
tumourigenesis in the longer term.
In summary, we have demonstrated that BMP signalling is active in
the adult airway epithelium during regeneration and that BMP4 alters
the morphology, downregulates E-cadherin expression and induces
migration in normal airway epithelial cells. Our data suggest that the
role played by BMPs in controlling tissue architecture during
development is recapitulated in adult airways during regeneration
after injury.
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